Stereotactic body radiation therapy for reirradiation of localized adenocarcinoma of the pancreas
Open Access
- 18 May 2012
- journal article
- research article
- Published by Springer Science and Business Media LLC in Radiation Oncology
- Vol. 7 (1), 74
- https://doi.org/10.1186/1748-717x-7-74
Abstract
Local control rates are poor in the treatment of pancreatic cancer. We investigated the role of hypofractionated stereotactic body radiation therapy (SBRT) for salvage or boost treatment after conventional doses of external beam radiation therapy. All patients treated with SBRT for pancreatic adenocarcinoma at Georgetown University from June 2002 through July 2007 were examined. Eligible patients had prior external beam radiation therapy to the pancreas. Treatment parameters and clinical and radiographic follow-up were evaluated. Twenty-eight patients were identified who received SBRT after a median prior external beam radiotherapy dose of 50.4 Gy. The median patient age was 63 years old and the median follow-up was 5.9 months. Twelve of fourteen (85.7%) evaluable patients were free from local progression, with three partial responses and nine patients with stable disease. Toxicity consisted of one case of acute Grade II nausea/vomiting, and two cases of Grade III late GI toxicity. The median overall survival was 5.9 months, with 18% survival and 70% freedom from local progression at one year. Hypofractionated SBRT reirradiation of localized pancreatic cancer is a well-tolerated treatment. Most patients are free from local progression, albeit with limited follow-up, but overall survival remains poor.Keywords
This publication has 22 references indexed in Scilit:
- Stereotactic Body Radiotherapy: A ReviewClinical Oncology, 2010
- EUS-guided fiducial placement for CyberKnife radiotherapy of mediastinal and abdominal malignanciesGastrointestinal Endoscopy, 2006
- On Statistical Reanalysis, the EORTC Trial Is a Positive Trial for Adjuvant Chemoradiation in Pancreatic CancerAnnals of Surgery, 2006
- Phase II study to assess the efficacy of conventionally fractionated radiotherapy followed by a stereotactic radiosurgery boost in patients with locally advanced pancreatic cancerInternational Journal of Radiation Oncology*Biology*Physics, 2005
- A Randomized Trial of Chemoradiotherapy and Chemotherapy after Resection of Pancreatic CancerThe New England Journal of Medicine, 2004
- Adjuvant Radiotherapy and 5-Fluorouracil After Curative Resection of Cancer of the Pancreas and Periampullary RegionAnnals of Surgery, 1999
- The Cyberknife: A Frameless Robotic System for RadiosurgeryStereotactic and Functional Neurosurgery, 1997
- Patterns of failure after curative resection of pancreatic carcinomaCancer, 1990
- Pancreatic CancerArchives of Surgery, 1985
- Carcinoma of the pancreas: Review of MGH experience from 1963 to 1973—Analysis of surgical failure and implications for radiation therapyCancer, 1976